Friday

22nd Oct 2021

Europeans receive unequal access to cancer treatment, report says

Europeans do not benefit from an equal access to cancer treatment, according to a report published on Friday (16 January) by the European Federation of Pharmaceutical Industries and Associations (EFPIA).

The research by Nils Wilking, clinical oncologist at the Karolinska Institutet in Stockholm, and Bengt Jonsson, professor of health economics at the Stockholm School of Economics, covers all EU states but Cyprus and Malta, as well as Iceland, Norway and Switzerland.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

  • Inequalities in access to cancer care remain within the EU (Photo: European Community, 2005)

It also shows disparities in the rates of survival from cancer, notably when comparing eastern Europe with northern and western Europe.

Sweden, Iceland, Finland, Austria and Belgium have the highest cancer survival rate, whereas the Czech Republic and Poland have the lowest.

In Sweden, 60.3 percent of men and 61.7 percent of women diagnosed with cancer survive compared to only 37.7 percent of men and 49.3 percent of women in the Czech Republic.

People in the Czech Republic and Poland also lag behind on access to new cancer treatment, compared to Austria, France and Switzerland, which lead the ranking, according to the report.

This is partly explained by the fact that in countries where the income per capita is lower, the access to new cancer drugs is lower too, even if drugs account for a large percentage of the total health care spending.

"The inequalities –highlighted in our original report in 2005 – still remain," Professor Jonsson stated.

"For patients and society this is a real concern, as expectations are that all patients in Europe should have equal opportunity to access these treatments, particularly when evidence shows that access to cancer treatment is linked to an improvement in outcome," he added.

To reach that goal, the report's authors suggest policy-makers should improve access to cancer treatment by "adapting healthcare budgets generally and hospital budgets specifically to incorporate the introduction of new cancer drugs."

Other means would include introducing separate funding for cancer drugs, and promoting a more collaborative European approach in order to collect as much available scientific information as possible.

In 2006, over 2.3 million new cases of cancer were diagnosed in Europe – a 10 percent increase compared to 2002 – while 1.2 million people died of the disease.

Opinion

On breast cancer our work is far from over

Breast cancer is still the most frequent cause of cancer death for women in Europe - but life expectancy of patients in Romania or Poland are lower than the EU average, and screening programmes vary hugely.

Stakeholder

The EU cannot let its patients down

Public health is being pushed into the background at EU level, while a cooperative and patient-centred approach could help to achieve a fairer and better healthcare system for European citizens.

MEPs call for workers to have 'right to disconnect'

MEPs called for a new law guaranteeing workers can 'disconnect' outside work hours, without repercussion. But they also passed a last-minute amendment, calling on the commission to delay any legislation for three years.

News in Brief

  1. Russia's anti-vax campaign backfired, EU says
  2. China angered as MEPs call for Taiwan talks
  3. Emissions from La Palma volcano reach Brussels
  4. Body of eighth victim of Belarus border-crisis found in river
  5. Report: Syrian bank fiddling currency to evade EU sanctions
  6. Nato adopts plan to counter new Russian threats
  7. Alleged killer of British MP 'felt affiliated' to IS
  8. Coronavirus: Belgium returns to 'red' zone

Opinion

Sweden's non-lockdown didn't work - why not?

The Swedish king would have been better advised to use his annual Christmas interview to call for unity of purpose and shed light on the political roots of the country's response.

Column

BioNTech: Stop talking about their 'migration background'

I understand that the German-Turkish community - often subjected to condescension in Germany - celebrated the story. Uğur Şahin and Özlem Türecki represent scientific excellence and business success at the highest level.

Stakeholders' Highlights

  1. Nordic Council of MinistersNew report reveals bad environmental habits
  2. Nordic Council of MinistersImproving the integration of young refugees
  3. Nordic Council of MinistersNATO Secretary General guest at the Session of the Nordic Council
  4. Nordic Council of MinistersCan you love whoever you want in care homes?
  5. Nordic Council of MinistersNineteen demands by Nordic young people to save biodiversity
  6. Nordic Council of MinistersSustainable public procurement is an effective way to achieve global goals

Latest News

  1. Gas price spike exposes rift at EU summit
  2. Poland vows not to give into EU 'blackmail' at summit
  3. EU vows to uphold Paris climate ambition amid scientists' fears
  4. Commissions's new migration pact still seeking 'landing zone'
  5. Europe can't ignore Chinese encroachment in Ukraine
  6. Lithuania - where 'biodiversity funding' is cutting down trees
  7. Dutch lawyers take Frontex to EU court over pushbacks
  8. Polish rule-of-law debate boils over to EU summit

Join EUobserver

Support quality EU news

Join us